近日，太阳城集团衡阳医学院王震教授团队的卓林胜博士在药物化学领域Top期刊European Journal of Medicinal Chemistry（IF：7.09，药物化学领域影响因子排名第二）上发表了题为“N(14)-substituted Evodiamine Derivatives as Dual Topoisomerase 1/Tubulin-Inhibiting Anti-Gastrointestinal Tumor Agents”（doi.org/10.1016/j.ejmech.2023.115366）的研究性论文。

文章来源：https://mp.weixin.qq.com/s?__biz=MzA3NzUyOTgyNA==&mid=2650875431&idx=1&sn=d7044eb4bfe54551737a1126fa1c889b&chksm=84a511a8b3d298bec72602513e006499155a3bcc798133dc98014144ecc37d042466ef81649f&mpshare=1&scene=23&srcid=04260DlBayxxPcHDHWusJBD6&sharer_sharetime=1682507275418&sharer_shareid=8b62c329cc5e532678ad89fc32464b68#rd